Drugs / LAYLA
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT02049606 | Feb 2014 → May 2015 | osteoarthritis, knee | PMG Pharm Co., Ltd | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LAYLA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02049606 ↗ |